|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
ENvue Medical, Inc. (Name of Issuer) |
Common Stock, par value $0.001 per share (Title of Class of Securities) |
29415F100 (CUSIP Number) |
Christian Glibert 4001 Green Heron Spring Drive, Carpinteria, CA, 93013 740-507-7228 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
01/14/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. | 29415F100 |
| 1 |
Name of reporting person
Glibert Christian Michael | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
240,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
22.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock, par value $0.001 per share |
| (b) | Name of Issuer:
ENvue Medical, Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
969 PRUITT AVE,, TYLER,
TEXAS
, 77569. |
| Item 2. | Identity and Background |
| (a) | Christian Michael Glibert |
| (b) | 4001 Green Heron Spring Drive, Carpinteria CA 93013 |
| (c) | Physical Therapist, investor. |
| (d) | none |
| (e) | none |
| (f) | United States of America |
| Item 3. | Source and Amount of Funds or Other Consideration |
Source: Personal Funds. Amount: $640,737.85 The source of funds for the purchase of the Common Stock was personal funds of the Reporting Person. No part of the purchase price was represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading, or voting the securities. | |
| Item 4. | Purpose of Transaction |
The Reporting Person acquired the Common Stock for investment purposes. Depending on market conditions and other factors, the Reporting Person may from time to time acquire additional securities of the Issuer or dispose of all or a portion of the securities.
Except as set forth above, the Reporting Person has no present plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | Aggregate Number: 240,000
Percentage: 22.05% (Based on 1,088,192 shares outstanding as of Feb 2026).
|
| (b) | Sole Voting Power: 240,000
Shared Voting Power: 0
Sole Dispositive Power: 240,000
Shared Dispositive Power: 0 |
| (c) | Recent Transactions: On January 14, 2026, the Reporting Person purchased 240,000 shares at average $2.67 price per share in an open market transaction. |
| (d) | Not applicable |
| (e) | Not applicable |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
There are no contracts, arrangements, understandings, or relationships (legal or otherwise) between the Reporting Person and any other person with respect to any securities of the Issuer. | |
| Item 7. | Material to be Filed as Exhibits. |
None |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|